Events

EuroHPC Access Calls Webinar
MAY
Wed
13
10:00 - 12:30

Starts in 2 weeks from now

Location

Online

Programmes
Digital, Industry & Space HPC AI Continent

The European High Performance Computing Joint Undertaking (EuroHPC JU), in co-organisation with the User Forum, organise a webinar to guide participants through the full lifecycle of applying for EuroHPC Access Calls.

EuroHPC Access Calls provide HPC users and developers from both public and private institutions the opportunity to apply for supercomputing resources across all EuroHPC JU machines. These calls are highly competitive and require a strong combination of scientific excellence and technical readiness. 

Talks will focus on:

  • proposal preparation
  • scientific and technical evaluation
  • benchmarking
  • successful project execution

More information on the event, including its agenda, and the possibility to register can be found on the event website

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.